Alpha Cognition develops and sells ZUNVEYL, an oral tablet for Alzheimer's disease. It last closed at $7.92 on Nov 17, up 1.15% on the day. ACOG last reported earnings on Wed, Nov 11, 2026.
Only 1 firm rated ACOG in the past 90 days, not enough for a consensus
Average 12-month target
$21.00
▲ 165.2% upside
Based on 1 analyst who set a price target on ACOG in the past 90 days. The average target is $21.00, with a high of $21.00 and a low of $21.00, compared with the last close of $7.92.
Low $21.00Avg $21.00High $21.00
Blue marker: last close $7.92
Highest target$21.00
Average target$21.00
Lowest target$21.00
Latest rating changes
B. Riley SecuritiesInitiated
Aug 20Buy$21
HC Wainwright & Co.Maintained
Aug 17Buy$20
Raymond JamesInitiated
Jul 10Buy$20
Maxim GroupInitiated
May 29Buy$12
Craig-HallumInitiated
Apr 17Buy$14
Date
Firm
Action
Rating
Price target
Aug 20
B. Riley Securities
Initiated
Buy
$21
Aug 17
HC Wainwright & Co.
Maintained
Buy
$20
Jul 10
Raymond James
Initiated
Buy
$20
May 29
Maxim Group
Initiated
Buy
$12
Apr 17
Craig-Hallum
Initiated
Buy
$14
Loading…
Technical Analysis
ACOG · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 7% below its 20 day and 9% below its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $7.81, and the nearest resistance the Pivot R1 at $8.03.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 6.0%/day
Key levels
$10.1452 week high+28.0%
$8.6750 day average+9.5%
$8.67100 day average+9.5%
$8.65Swing high (Jul 22)+9.2%
$8.5020 day average+7.3%
$8.03Pivot R1+1.4%
$7.92Pivot+0.0%
$7.92Last close
$7.81Pivot S1−1.4%
$7.54Swing low (Jul 31)−4.8%
$7.32200 day average−7.6%
$4.5052 week low−43.2%
Indicators
RSI (14)
40.15
Middle of its range
Neutral
MACD
-0.15
Below its signal line
Bearish
Stochastic
9.8
Near the bottom of its range
Oversold
ADX (14)
14.5
No clear trend
Williams %R
-92.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-146.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−3.4%
Change over 10 sessions
Bearish
ATR (14)
$0.48
Typical daily range, 6.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityLow, 12.8%/day
Key levels
$10.1452 week high+28.0%
$8.6750 day average+9.5%
$8.67100 day average+9.5%
$8.65Swing high (Jul 22)+9.2%
$8.5020 day average+7.3%
$8.03Pivot R1+1.4%
$7.92Pivot+0.0%
$7.92Last close
$7.81Pivot S1−1.4%
$7.54Swing low (Jul 31)−4.8%
$7.32200 day average−7.6%
$4.5052 week low−43.2%
Indicators
RSI (14)
48.39
Middle of its range
Neutral
MACD
0.31
Below its signal line
Bearish
Stochastic
15.6
Near the bottom of its range
Oversold
ADX (14)
23.9
Weak trend
Williams %R
-95.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-126.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.0%
Change over 10 sessions
Bearish
ATR (14)
$1.01
Typical daily range, 12.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for ACOG
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ACOG did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in ACOG in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACOG is in one of them and how their past ACOG trades turned out.
Alpha Cognition is a biopharmaceutical company based in Grapevine, Texas, that develops treatments for neurodegenerative diseases, with a focus on Alzheimer's disease. Its main product is ZUNVEYL, an oral tablet for mild to moderate dementia of the Alzheimer's type. The company sells ZUNVEYL to nursing homes that care for Alzheimer's patients, working with physicians, pharmacies and pharmacy benefit managers to expand access. It also has earlier stage programs and has licensed ZUNVEYL rights in parts of Asia, Australia and New Zealand.